Navigation Links
B. Braun to Showcase Its Safety-Engineered IV Therapy Portfolio at AVA
Date:9/9/2013

BETHLEHEM, Pa., Sept. 9, 2013 /PRNewswire/ -- B. Braun Medical Inc. (B.Braun) will exhibit and host a Platinum Showcase presentation at the 27th Association for Vascular Access (AVA) Annual Scientific Meeting in Nashville, Tennessee, September 20th-23rd. The presentation entitled "Navigating the Depths: Ultrasound Guided Short PIV Insertions -- Implications and Limitations for Practice" will feature a discussion of technology and procedures related to ultrasound guided peripheral IV insertion that highlights standardized approaches to patient assessment and techniques for vessel access.

Robert B. Dawson, DNP, MSA, RN, VA-BC, CRNI, CPUI, Vascular Access Consultant, PICC Academy and Leianne Jinkins, RN, BSN, VA-BC, CPUI, Vascular Access Specialist, B.Braun will be the featured presenters. The presentation will take place on Saturday, September 21, 2013 from 2-3 p.m. at the Gaylord Opryland Hotel (Hermitage-E). 

Click here for an audio Podcast presentation preview of Robert Dawson.

Catheter-related bloodstream infections (CRBSIs), needlestick (sharps) injuries and exposure to potentially deadly blood borne pathogens continue to be major issues facing all healthcare professionals.  

"B.Braun remains committed to combating these issues by providing a robust portfolio of safety-engineered IV therapy devices that offer patient protection against infection and optimum safety for clinicians in the workplace," said Tom Sutton, Vice President of Vascular Access Systems at B.Braun.

B.Braun will demonstrate the following safety-engineered IV therapy devices at booth (#202) during AVA.  When attendees gain vascular access by using one of the following innovative products, B.Braun will make a donation to the AVA Foundation, which supports vascular access education and outreach.  

  • Introcan Safety® IV Catheter, which is designed with innovative passive-safety features to help eliminate accidental needlestick injury -- effortlessly. From insertion to catheter deployment to needle removal, clinicians are protected by a truly passive safety device that is activated automatically -- no extra steps required and cannot be bypassed.
  • Introcan Safety® 3 Closed IV Catheter, B.Braun's latest innovation, which takes the same preferred passive safety-engineered needlestick protection found in Introcan Safety and adds additional protection from blood exposure. For safety and convenience, the Introcan Safety 3's unique multi-access blood control septum minimizes blood exposure during needle removal and each time the catheter hub is accessed.
  • B.Braun's WHIN® Safe Huber Needle, the clear choice for implantable port access, integrating the design features of two safety devices in a single huber needle -- protecting clinicians from both needlestick injuries, and expelled blood and fluid. With an easy-to-dress design, the device includes a safety shield that covers the needle tip as it is withdrawn, for both clinician and patient safety.
  • Caresite® Luer Access Device, the latest in B.Braun's needleless connector portfolio that offers a safe way to access IV lines without the use of a needle, which reduces the risk of accidental needlestick injuries. Input from clinicians provided the basis for the CARESITE design. The result is a device designed to help improve patient outcomes and clinician efficiency. CARESITE needleless connector with innovative positive displacement feature is designed to help reduce catheter occlusions while preventing healthcare workers from accidental needlestick injuries.

To learn more about B.Braun visit www.BBraunUSA.com

About B. Braun

B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The Company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. Guided by its "Sharing Expertise®" philosophy, B.Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs.

The B.Braun Group of Companies in the U.S. includes B.Braun, Aesculap® and CAPS®. B.Braun's U.S. headquarters is located in Bethlehem, Pennsylvania. The B.Braun Group of Companies employs more than 46,000 employees in more than 50 countries throughout the world. To learn more about B.Braun visit www.BBraunUSA.com.


'/>"/>
SOURCE B. Braun Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Awarded Premier Healthcare Alliance Contract for Dual-Source IV
2. Patient and Healthcare Worker Safety Major Areas of Focus at B.Braun
3. B. Braun Smart Infusion Pump Technology to be Featured in Integrating the Healthcare Enterprise (IHE) Interoperability Demonstration at AAMI 2013
4. B. Braun Committed To Improving Patient Safety
5. B. Braun Reveals Customer Satisfaction Survey
6. B. Braun Committed to Protecting Healthcare Workers from Exposure to Hazardous Drugs
7. B. Braun Launches New Patient Website
8. B. Braun Smart Infusion Pump Technology Advances Patient Safety and Treatment Efficiency
9. B. Braun Joins National Health Organization Supporting Environmental Practices
10. Novation Innovative Technology Expo To Showcase Products that Improve Patient Outcomes, Increase Safety
11. Medical Supplies Specialist Med Supply Shop Showcases Its New Range of Incontinence Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... BOSTON , March 27, 2017 /PRNewswire/ ... through a data-driven, biological research approach, today ... contributed to the discovery of new data ... and facilitate brown fat metabolism. Joslin Diabetes ... its Interrogative Biology® platform for analysis of ...
(Date:3/27/2017)... -- On Friday, benchmark US indices were ... trading session up 0.19%; the Dow Jones Industrial Average ... 0.08%. US markets made broad based gains with five ... Pre-market today, Stock-Callers.com reviews these four Medical Appliances & ... Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: MDXG), and ...
(Date:3/27/2017)... , March 27, 2017  Allergan plc, ... Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company ... therapies based upon tetracycline chemistry, announced that two ... treatment of moderate to severe acne met their ... once-daily, oral, narrow spectrum tetracycline-derived antibiotic with anti-inflammatory ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin Harper, Founder ... few medical professionals in the country to sit on the 2017 National Advisory Board ... just 2 years Dr. Harper helped propel the clinic from a small start-up to ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Public relations pros ... across a variety of business channels. , While many results are clear, much of ... relations program. , When it comes to measurement, firms should always take an ...
(Date:3/28/2017)... ... , ... Oily skin is a common and unwelcomed occurrence in people of all ages, genders ... offer to the discussion of dealing with excess skin oil. “Oily skin is a challenge ... that can help remove the oily shine while keeping the skin fresh and clean,” says ...
(Date:3/28/2017)... California (PRWEB) , ... March 28, 2017 , ... Bacteria and fungi are probably not ... microorganisms are bad. In fact, including the right microorganisms in your diet can actually improve ... favorite foods. , This is the topic of a new peer-reviewed paper ...
(Date:3/27/2017)... ... 2017 , ... New patients who want to experience the benefits of ... them placed by Dr. Manju Kejriwal, with or without a referral. Dr. Kejriwal is ... accuracy of each dental implant placement. The i-CAT CBCT system captures the shapes of ...
Breaking Medicine News(10 mins):